| 1 |
34413963 | Structure-Activity Relationship Studies Reveal New Astemizole Analogues Active against Plasmodium falciparum In Vitro. | 2021 Aug 12 |
1 |
| 2 |
26804230 | Optimization of tetrahydronaphthalene inhibitors of Raf with selectivity over hERG. | 2016 Feb 15 |
1 |
| 3 |
26141771 | Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6). | 2015 Sep 1 |
1 |
| 4 |
24412109 | Successful reduction of off-target hERG toxicity by structural modification of a T-type calcium channel blocker. | 2014 Feb 1 |
1 |
| 5 |
24486132 | IV. Discovery of CXCR3 antagonists substituted with heterocycles as amide surrogates: improved PK, hERG and metabolic profiles. | 2014 Feb 15 |
1 |
| 6 |
21414780 | Novel pyrrolidine melanin-concentrating hormone receptor 1 antagonists with reduced hERG inhibition. | 2011 Apr 15 |
1 |
| 7 |
21515049 | Macrocyclic lactams as potent Hsp90 inhibitors with excellent tumor exposure and extended biomarker activity. | 2011 Jun 1 |
1 |
| 8 |
20570511 | Discovery of aminopyridines substituted with benzoxazole as orally active c-Met kinase inhibitors. | 2010 Jul 15 |
1 |
| 9 |
20684603 | Discovery of 6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-2-carboxamides as potent, selective dipeptidyl peptidase-4 (DPP4) inhibitors. | 2010 Aug 12 |
1 |
| 10 |
19821563 | Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety. | 2009 Nov 12 |
1 |